| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 24.27B | 29.37B | 23.83B | 17.46B | 20.78B | 23.60B |
| Gross Profit | 9.98B | 12.66B | 9.35B | 5.19B | 7.34B | 8.93B |
| EBITDA | 6.15B | 8.68B | 5.78B | 1.94B | 4.31B | 5.97B |
| Net Income | 3.57B | 5.45B | 3.45B | 622.00M | 2.61B | 3.80B |
Balance Sheet | ||||||
| Total Assets | 37.80B | 58.48B | 39.86B | 35.08B | 32.96B | 33.21B |
| Cash, Cash Equivalents and Short-Term Investments | 13.71B | 27.15B | 12.19B | 14.25B | 12.81B | 11.87B |
| Total Debt | 5.50B | 7.54B | 5.88B | 5.66B | 4.18B | 5.19B |
| Total Liabilities | 9.75B | 13.60B | 11.94B | 10.41B | 8.72B | 11.42B |
| Stockholders Equity | 28.05B | 44.88B | 27.91B | 24.67B | 24.24B | 21.79B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.24B | -1.66B | 397.00M | 2.43B | 3.89B |
| Operating Cash Flow | 0.00 | 5.76B | 1.80B | 2.31B | 3.35B | 4.81B |
| Investing Cash Flow | 0.00 | -3.66B | -3.58B | -2.20B | -849.00M | -562.00M |
| Financing Cash Flow | 0.00 | 12.71B | -514.00M | 879.00M | -1.58B | 947.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥530.84B | 20.39 | ― | 1.02% | 32.81% | 59.74% | |
73 Outperform | ¥239.40B | 21.97 | ― | 3.09% | 11.04% | -3.91% | |
72 Outperform | ¥98.29B | 12.23 | ― | 1.72% | 23.24% | 55.74% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | ¥443.11B | 19.76 | 5.77% | 3.28% | 5.30% | -4.93% | |
52 Neutral | ¥1.06T | -17.13 | ― | 1.14% | 0.75% | -230.21% |